Diversified Trust’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-88,317
Closed -$696K 1061
2025
Q3
$696K Buy
88,317
+4,775
+6% +$34K 0.01% 517
2025
Q2
$479K Hold
83,542
0.01% 605
2025
Q1
$682K Buy
83,542
+1,784
+2% +$16.5K 0.02% 472
2024
Q4
$770K Buy
81,758
+7,257
+10% +$75.4K 0.02% 453
2024
Q3
$796K Buy
74,501
+2,698
+4% +$29.4K 0.02% 448
2024
Q2
$712K Buy
71,803
+5,170
+8% +$53.1K 0.02% 438
2024
Q1
$785K Buy
66,633
+3,938
+6% +$50.4K 0.02% 396
2023
Q4
$890K Buy
62,695
+4,633
+8% +$52.6K 0.03% 319
2023
Q3
$706K Buy
58,062
+18,049
+45% +$233K 0.03% 345
2023
Q2
$503K Hold
40,013
0.02% 457
2023
Q1
$444K Buy
40,013
+1,838
+5% +$22.7K 0.02% 507
2022
Q4
$466K Hold
38,175
0.02% 444
2022
Q3
$399K Sell
38,175
-1,851
-5% -$20.6K 0.02% 459
2022
Q2
$430K Sell
40,026
-27
-0.1% -$222 0.02% 437
2022
Q1
$379K Hold
40,053
0.01% 542
2021
Q4
$463K Buy
40,053
+2,827
+8% +$31.5K 0.02% 482
2021
Q3
$356K Sell
37,226
-254
-0.7% -$2.6K 0.01% 523
2021
Q2
$361K Buy
+37,480
New +$366K 0.01% 492
2020
Q4
Sell
-32,037
Closed -$452K 755
2020
Q3
$452K Sell
32,037
-16,372
-34% -$239K 0.02% 332
2020
Q2
$730K Buy
+48,409
New +$590K 0.04% 202

Other funds holding FOLD

Diversified Trust's FOLD Position: Q4 2025 in Review

Diversified Trust sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 88,317 shares — an estimated $696K sold.

Diversified Trust first reported a position in FOLD in Q2 2020 and held it in 20 quarters. The position peaked at $890K in Q4 2023. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • Diversified Trust reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Diversified Trust sold 88,317 Amicus Therapeutics shares in Q4 2025, an estimated $696K.
  • Diversified Trust first reported a position in Amicus Therapeutics in Q2 2020 and held it in 20 quarters.
  • Diversified Trust's Amicus Therapeutics position peaked at $890K in Q4 2023.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on Diversified Trust's 13F filing for Q4 2025, filed 9 Jan 2026.